Snapchat adds multi-CTA ad format for pharma disclosure needs
Snapchat is adding a pharma ad format with up to three disclaimer CTAs for safety, patient and prescribing information in one unit.
Image: Snapchat
NAD recommends changes to Sanofi Dupixent advertising
After Galderma’s challenge, NAD advised Sanofi to change selected Dupixent advertising claims on clearer skin and itch relief.
Quanterix appoints Jim Gute as Chief Commercial Officer
Quanterix has named Jim Gute Chief Commercial Officer, tasking him with leading commercial growth across biomarker testing and diagnostics.
Statutory reimbursement for cannabis flower ends without transition period
Germany’s statutory reimbursement for cannabis flower ended on 30 July. An industry initiative seeks transition rules for ongoing therapies.
Bübchen continues Supersanft baby care campaign
Bübchen and Antoni Soap continue the Supersanft campaign, highlighting product benefits across social media and Connected TV in Germany.
BARMER CEO Christoph Straub to step down at the end of 2026
Christoph Straub will step down as BARMER’s board chairman at the end of 2026. Simone Schwering and Uwe Repschläger will follow.
GSK plans new global R&D centre in Cambridge
GSK will invest £400 million in a new Cambridge R&D centre and shift UK research operations from Stevenage by 2029.
Hansaplast expands global social media strategy
Hansaplast is reshaping global social media. Charles & Charlotte will lead strategy and execution for the wound care brand in 17 markets.
Simon Goeller to lead Sandoz in Germany
Sandoz has appointed Dr. Simon Goeller as Country President in Germany. He also takes on the CEO role at Hexal.
Bausch + Lomb highlights two product launches
Bausch + Lomb highlights two launches: a vitrectomy cutter for Europe and preservative-free lubricant eye drops in the United States.